Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

NanOlogy enrols first patient in phase 2 trial of NanoPac for intratumoral treatment of prostate cancer

pharmaceutical-business-reviewNovember 10, 2020

Tag: NanOlogy , NanoPac , Prostate Cancer

PharmaSources Customer Service